Efficacy of intravitreal injection of bevacizumab in vitrectomy for patients with proliferative vitreoretinopathy retinal detachment: A meta-analysis of prospective studies
Retina | Mar 02, 2018
Zhao XY, et al. - Researchers, herein, assessed the effect of intravitreal injection of bevacizumab in vitrectomy for patients with proliferative vitreoretinopathy (PVR)-related retinal detachment. No decrease in the retinal redetachment rate or improvement in the visual acuity was noted with the intravitreal injection of bevacizumab in vitrectomy for these patients.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries